News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
326,645 Results
Type
Article (25786)
Company Profile (32)
Press Release (300827)
Multimedia
Podcasts (123)
Webinars (5)
Section
Business (81706)
Career Advice (876)
Deals (13565)
Drug Delivery (67)
Drug Development (51472)
Employer Resources (69)
FDA (9405)
Job Trends (7182)
News (157556)
Policy (16153)
Tag
Academia (1882)
Accelerated approval (2)
Adcomms (14)
Allergies (45)
Alliances (19050)
ALS (65)
Alzheimer's disease (1012)
Antibody-drug conjugate (ADC) (63)
Approvals (9424)
Artificial intelligence (121)
Autoimmune disease (11)
Automation (11)
Bankruptcy (144)
Best Places to Work (6305)
BIOSECURE Act (13)
Biosimilars (29)
Biotechnology (19)
Bladder cancer (66)
Brain cancer (18)
Breast cancer (168)
Cancer (1423)
Cardiovascular disease (186)
Career advice (741)
Career pathing (16)
CAR-T (90)
Cell therapy (256)
Cervical cancer (14)
Clinical research (42168)
Collaboration (359)
Compensation (163)
Complete response letters (12)
COVID-19 (1357)
CRISPR (27)
C-suite (95)
Cystic fibrosis (59)
Data (1729)
Decentralized trials (2)
Denatured (43)
Depression (24)
Diabetes (179)
Diagnostics (3297)
Digital health (8)
Diversity (7)
Diversity, equity & inclusion (24)
Drug discovery (61)
Drug pricing (75)
Drug shortages (21)
Duchenne muscular dystrophy (74)
Earnings (35282)
Editorial (18)
Employer branding (4)
Employer resources (61)
Events (49353)
Executive appointments (308)
FDA (10292)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (362)
Gene editing (74)
Generative AI (8)
Gene therapy (244)
GLP-1 (488)
Government (2757)
Grass and pollen (3)
Guidances (110)
Healthcare (10526)
Huntington's disease (10)
IgA nephropathy (22)
Immunology and inflammation (57)
Indications (18)
Infectious disease (1442)
Inflammatory bowel disease (73)
Inflation Reduction Act (8)
Influenza (26)
Intellectual property (51)
Interviews (112)
IPO (6982)
IRA (30)
Job creations (1142)
Job search strategy (672)
Kidney cancer (10)
Labor market (10)
Layoffs (171)
Leadership (10)
Legal (2889)
Liver cancer (40)
Lung cancer (193)
Lymphoma (109)
Machine learning (6)
Management (26)
Manufacturing (131)
MASH (85)
Medical device (6932)
Medtech (6934)
Mergers & acquisitions (6831)
Metabolic disorders (504)
Multiple sclerosis (42)
NASH (20)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (1349)
NextGen: Class of 2025 (3326)
Non-profit (3049)
Now hiring (30)
Obesity (248)
Opinion (108)
Ovarian cancer (46)
Pain (71)
Pancreatic cancer (65)
Parkinson's disease (92)
Partnered (10)
Patents (118)
Patient recruitment (74)
Peanut (23)
People (23798)
Pharmaceutical (14)
Pharmacy benefit managers (12)
Phase I (12262)
Phase II (18581)
Phase III (14368)
Pipeline (886)
Policy (103)
Postmarket research (2010)
Preclinical (5672)
Press Release (19)
Prostate cancer (68)
Psychedelics (12)
Radiopharmaceuticals (133)
Rare diseases (249)
Real estate (1845)
Recruiting (22)
Regulatory (11810)
Reports (13)
Research institute (1391)
Resumes & cover letters (119)
Rett syndrome (6)
RNA editing (2)
RSV (24)
Schizophrenia (47)
Series A (52)
Series B (37)
Service/supplier (1)
Sickle cell disease (36)
Special edition (5)
Spinal muscular atrophy (80)
Sponsored (13)
Startups (1410)
Stomach cancer (3)
Supply chain (29)
Tariffs (16)
The Weekly (78)
Vaccines (331)
Venture capitalists (15)
Weight loss (155)
Women's health (26)
Worklife (8)
Date
Today (104)
Last 7 days (598)
Last 30 days (1898)
Last 365 days (17560)
2025 (6504)
2024 (18915)
2023 (21268)
2022 (25898)
2021 (27881)
2020 (26797)
2019 (24067)
2018 (18140)
2017 (15732)
2016 (15103)
2015 (18134)
2014 (13149)
2013 (10536)
2012 (11330)
2011 (11868)
2010 (11111)
Location
Africa (322)
Alabama (33)
Alaska (3)
Arizona (88)
Arkansas (8)
Asia (16371)
Australia (3334)
California (3414)
Canada (1030)
China (285)
Colorado (142)
Connecticut (144)
Delaware (81)
Europe (40653)
Florida (515)
Georgia (121)
Idaho (22)
Illinois (299)
India (11)
Indiana (179)
Iowa (4)
Japan (98)
Kansas (73)
Kentucky (12)
Louisiana (8)
Maine (29)
Maryland (499)
Massachusetts (2278)
Michigan (90)
Minnesota (193)
Mississippi (1)
Missouri (46)
Montana (15)
Nebraska (12)
Nevada (43)
New Hampshire (34)
New Jersey (1107)
New Mexico (11)
New York (1015)
North Carolina (565)
North Dakota (4)
Northern California (1552)
Ohio (126)
Oklahoma (6)
Oregon (18)
Pennsylvania (724)
Puerto Rico (7)
Rhode Island (9)
South America (532)
South Carolina (21)
South Dakota (1)
Southern California (1330)
Tennessee (69)
Texas (497)
United States (12747)
Utah (99)
Virginia (87)
Washington D.C. (43)
Washington State (334)
West Virginia (1)
Wisconsin (21)
326,645 Results for "american heart association aha".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Idorsia is advancing the treatment of hypertension with new data at the 2024 American Heart Association (AHA) Scientific Sessions
November 12, 2024
·
5 min read
Press Releases
SonoThera to Present Preclinical Data on Ultrasound-Mediated Gene Delivery Platform to the Heart at the American Heart Association (AHA) Scientific Sessions 2024
November 11, 2024
·
2 min read
Press Releases
Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting
November 18, 2024
·
7 min read
Press Releases
Post-Hoc Analysis Demonstrating Sotagliflozin Benefits Across Broad Spectrum of Heart Failure Patient Populations is Among Four Lexicon-Supported Presentations at the American Heart Association’s (AHA) Sessions 2024 in Chicago
November 15, 2024
·
5 min read
Press Releases
Scribe Therapeutics to Present Preclinical Data on CRISPR Genome and Epigenome Editing Technologies at American Heart Association (AHA) Scientific Sessions 2024
October 30, 2024
·
3 min read
Press Releases
Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions
November 18, 2024
·
3 min read
Press Releases
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
·
5 min read
Press Releases
Investigators to Present New REDUCE-IT Subanalysis of VASCEPA®/VAZKEPA® (icosapent ethyl) in Patients With and Without Coronary Artery Disease History and Mechanistic Data on Eicosapentaenoic Acid (EPA) at the American Heart Association’s (AHA) Annual Scientific Sessions
November 11, 2024
·
10 min read
Press Releases
ZyVersa Therapeutics Highlights Data Published in the Journal of the American Heart Association Demonstrating Inflammasome Inhibition Attenuates Obesity-Associated Cardiomyopathy in Animal Model Study
March 19, 2025
·
6 min read
Drug Development
CRISPR Therapeutics Announces Preclinical Data at the American Heart Association (AHA) Scientific Sessions 2023
CRISPR Therapeutics announced preclinical data from the Company’s investigational programs for the treatment of cardiovascular disease, at the American Heart Association Scientific Sessions 2023.
November 6, 2023
·
6 min read
1 of 32,665
Next
